Vectors

Enzyme protects cells during gene therapy

Published in Gene Therapy Weekly, February 26th, 2004

An enzyme instrumental to the body's ability to repair itself appears to also stop a gene therapy virus from damaging a cell once the virus delivers its corrective cargo, University of Florida scientists report.

Gene therapy has been heralded as one of medicine's most promising frontiers, but as with any uncharted territory, dangers lurk. A key concern has been whether the viruses used to ferry therapeutic genes into cells to treat diseases such as Parkinson or diabetes also cause a second, unwanted effect: genetic mutations that ultimately trigger cancer. That fear was heightened last year when two boys with an immune system disorder developed leukemia after undergoing...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Gene Therapy Weekly

Source: Gene Therapy Weekly (2004-02-26)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry